Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 314 entries
Sorted by: Best Match Show Resources per page
Temporal cardiac remodeling post-myocardial infarction: dynamics and prognostic implications in personalized medicine.

Heart failure reviews

Altara R, Manca M, Sabra R, Eid AA, Booz GW, Zouein FA.
PMID: 26498937
Heart Fail Rev. 2016 Jan;21(1):25-47. doi: 10.1007/s10741-015-9513-8.

Despite dramatic improvements in short-term mortality rates following myocardial infarction (MI), long-term survival for MI patients who progress to heart failure remains poor. MI occurs when the left ventricle (LV) is deprived of oxygen for a sufficient period of...

Cite
Altara R, Manca M, Sabra R, et al. Temporal cardiac remodeling post-myocardial infarction: dynamics and prognostic implications in personalized medicine. Heart Fail Rev. 2016;21(1):25-47doi: 10.1007/s10741-015-9513-8.
Altara, R., Manca, M., Sabra, R., Eid, A. A., Booz, G. W., & Zouein, F. A. (2016). Temporal cardiac remodeling post-myocardial infarction: dynamics and prognostic implications in personalized medicine. Heart failure reviews, 21(1), 25-47. https://doi.org/10.1007/s10741-015-9513-8
Altara, Raffaele, et al. "Temporal cardiac remodeling post-myocardial infarction: dynamics and prognostic implications in personalized medicine." Heart failure reviews vol. 21,1 (2016): 25-47. doi: https://doi.org/10.1007/s10741-015-9513-8
Altara R, Manca M, Sabra R, Eid AA, Booz GW, Zouein FA. Temporal cardiac remodeling post-myocardial infarction: dynamics and prognostic implications in personalized medicine. Heart Fail Rev. 2016 Jan;21(1):25-47. doi: 10.1007/s10741-015-9513-8. PMID: 26498937.
Copy Download .nbib Format: NLM
Phenotypes of hypertrophic cardiomyopathy: genetics, clinics, and modular imaging.

Heart failure reviews

Muresan ID, Agoston-Coldea L.
PMID: 32040801
Heart Fail Rev. 2021 Sep;26(5):1023-1036. doi: 10.1007/s10741-020-09931-1.

Hypertrophic cardiomyopathy (HCM) is the most common cardiovascular disease with genetic transmission, characterized by the hypertrophy of any segment of the left ventricle (LV), not totally explained by improper loading conditions, with LV systolic function preserved, increased, or reduced....

Cite
Muresan ID, Agoston-Coldea L. Phenotypes of hypertrophic cardiomyopathy: genetics, clinics, and modular imaging. Heart Fail Rev. 2021;26(5):1023-1036doi: 10.1007/s10741-020-09931-1.
Muresan, I. D., & Agoston-Coldea, L. (2021). Phenotypes of hypertrophic cardiomyopathy: genetics, clinics, and modular imaging. Heart failure reviews, 26(5), 1023-1036. https://doi.org/10.1007/s10741-020-09931-1
Muresan, Ioana Danuta, and Agoston-Coldea, Lucia. "Phenotypes of hypertrophic cardiomyopathy: genetics, clinics, and modular imaging." Heart failure reviews vol. 26,5 (2021): 1023-1036. doi: https://doi.org/10.1007/s10741-020-09931-1
Muresan ID, Agoston-Coldea L. Phenotypes of hypertrophic cardiomyopathy: genetics, clinics, and modular imaging. Heart Fail Rev. 2021 Sep;26(5):1023-1036. doi: 10.1007/s10741-020-09931-1. PMID: 32040801.
Copy Download .nbib Format: NLM
Targeting the forkhead box protein P1 pathway as a novel therapeutic approach for cardiovascular diseases.

Heart failure reviews

Liu XM, Du SL, Miao R, Wang LF, Zhong JC.
PMID: 32648149
Heart Fail Rev. 2020 Jul 09; doi: 10.1007/s10741-020-09992-2. Epub 2020 Jul 09.

Cardiovascular disease (CVD) is the leading cause of death worldwide and encompasses diverse diseases of the vasculature, myocardium, cardiac electrical circuit, and cardiac development. Forkhead box protein P1 (Foxp1) is a large multi-domain transcriptional regulator belonging to the Fox...

Cite
Liu XM, Du SL, Miao R, et al. Targeting the forkhead box protein P1 pathway as a novel therapeutic approach for cardiovascular diseases. Heart Fail Rev. 2020;doi: 10.1007/s10741-020-09992-2.
Liu, X. M., Du, S. L., Miao, R., Wang, L. F., & Zhong, J. C. (2020). Targeting the forkhead box protein P1 pathway as a novel therapeutic approach for cardiovascular diseases. Heart failure reviews, . https://doi.org/10.1007/s10741-020-09992-2
Liu, Xin-Ming, et al. "Targeting the forkhead box protein P1 pathway as a novel therapeutic approach for cardiovascular diseases." Heart failure reviews vol. (2020). doi: https://doi.org/10.1007/s10741-020-09992-2
Liu XM, Du SL, Miao R, Wang LF, Zhong JC. Targeting the forkhead box protein P1 pathway as a novel therapeutic approach for cardiovascular diseases. Heart Fail Rev. 2020 Jul 09; doi: 10.1007/s10741-020-09992-2. Epub 2020 Jul 09. PMID: 32648149.
Copy Download .nbib Format: NLM
Nutritional interventions for heart failure patients who are malnourished or at risk of malnutrition or cachexia: a systematic review and meta-analysis.

Heart failure reviews

Habaybeh D, de Moraes MB, Slee A, Avgerinou C.
PMID: 32124164
Heart Fail Rev. 2021 Sep;26(5):1103-1118. doi: 10.1007/s10741-020-09937-9.

Malnutrition is common in heart failure (HF), and it is associated with higher hospital readmission and mortality rates. This review aims to answer the question whether nutritional interventions aiming to increase protein and energy intake are effective at improving...

Cite
Habaybeh D, de Moraes MB, Slee A, et al. Nutritional interventions for heart failure patients who are malnourished or at risk of malnutrition or cachexia: a systematic review and meta-analysis. Heart Fail Rev. 2021;26(5):1103-1118doi: 10.1007/s10741-020-09937-9.
Habaybeh, D., de Moraes, M. B., Slee, A., & Avgerinou, C. (2021). Nutritional interventions for heart failure patients who are malnourished or at risk of malnutrition or cachexia: a systematic review and meta-analysis. Heart failure reviews, 26(5), 1103-1118. https://doi.org/10.1007/s10741-020-09937-9
Habaybeh, Dina, et al. "Nutritional interventions for heart failure patients who are malnourished or at risk of malnutrition or cachexia: a systematic review and meta-analysis." Heart failure reviews vol. 26,5 (2021): 1103-1118. doi: https://doi.org/10.1007/s10741-020-09937-9
Habaybeh D, de Moraes MB, Slee A, Avgerinou C. Nutritional interventions for heart failure patients who are malnourished or at risk of malnutrition or cachexia: a systematic review and meta-analysis. Heart Fail Rev. 2021 Sep;26(5):1103-1118. doi: 10.1007/s10741-020-09937-9. PMID: 32124164; PMCID: PMC8310486.
Copy Download .nbib Format: NLM
Correction to: Flow-mediated dilation and heart failure: a review with implications to physical rehabilitation.

Heart failure reviews

Areas GPT, Mazzuco A, Caruso FR, Jaenisch RB, Cabiddu R, Phillips SA, Arena R, Borghi-Silva A.
PMID: 31713084
Heart Fail Rev. 2020 May;25(3):549. doi: 10.1007/s10741-019-09885-z.

The scholarship support information in Acknowledgement was missing.

Cite
Areas GPT, Mazzuco A, Caruso FR, et al. Correction to: Flow-mediated dilation and heart failure: a review with implications to physical rehabilitation. Heart Fail Rev. 2020;25(3):549doi: 10.1007/s10741-019-09885-z.
Areas, G. P. T., Mazzuco, A., Caruso, F. R., Jaenisch, R. B., Cabiddu, R., Phillips, S. A., Arena, R., & Borghi-Silva, A. (2020). Correction to: Flow-mediated dilation and heart failure: a review with implications to physical rehabilitation. Heart failure reviews, 25(3), 549. https://doi.org/10.1007/s10741-019-09885-z
Areas, G P T, et al. "Correction to: Flow-mediated dilation and heart failure: a review with implications to physical rehabilitation." Heart failure reviews vol. 25,3 (2020): 549. doi: https://doi.org/10.1007/s10741-019-09885-z
Areas GPT, Mazzuco A, Caruso FR, Jaenisch RB, Cabiddu R, Phillips SA, Arena R, Borghi-Silva A. Correction to: Flow-mediated dilation and heart failure: a review with implications to physical rehabilitation. Heart Fail Rev. 2020 May;25(3):549. doi: 10.1007/s10741-019-09885-z. PMID: 31713084.
Copy Download .nbib Format: NLM
Comprehensive assessment of hypertensive heart disease: cardiac magnetic resonance in focus.

Heart failure reviews

Tadic M, Cuspidi C, Plein S, Milivojevic IG, Wang DW, Grassi G, Mancia G.
PMID: 32170529
Heart Fail Rev. 2021 Nov;26(6):1383-1390. doi: 10.1007/s10741-020-09943-x.

Arterial hypertension represents the most frequent cardiovascular risk factor that is associated with cardiac remodeling. Hypertensive heart disease was defined by the presence of left ventricular hypertrophy (LVH) and diastolic dysfunction, and it has been diagnosed by echocardiography in...

Cite
Tadic M, Cuspidi C, Plein S, et al. Comprehensive assessment of hypertensive heart disease: cardiac magnetic resonance in focus. Heart Fail Rev. 2021;26(6):1383-1390doi: 10.1007/s10741-020-09943-x.
Tadic, M., Cuspidi, C., Plein, S., Milivojevic, I. G., Wang, D. W., Grassi, G., & Mancia, G. (2021). Comprehensive assessment of hypertensive heart disease: cardiac magnetic resonance in focus. Heart failure reviews, 26(6), 1383-1390. https://doi.org/10.1007/s10741-020-09943-x
Tadic, Marijana, et al. "Comprehensive assessment of hypertensive heart disease: cardiac magnetic resonance in focus." Heart failure reviews vol. 26,6 (2021): 1383-1390. doi: https://doi.org/10.1007/s10741-020-09943-x
Tadic M, Cuspidi C, Plein S, Milivojevic IG, Wang DW, Grassi G, Mancia G. Comprehensive assessment of hypertensive heart disease: cardiac magnetic resonance in focus. Heart Fail Rev. 2021 Nov;26(6):1383-1390. doi: 10.1007/s10741-020-09943-x. PMID: 32170529.
Copy Download .nbib Format: NLM
Mechanical circulatory support in patients with cardiogenic shock not secondary to cardiotomy: a network meta-analysis.

Heart failure reviews

Benenati S, Toma M, Canale C, Vergallo R, Bona RD, Ricci D, Canepa M, Crimi G, Santini F, Ameri P, Porto I.
PMID: 33677732
Heart Fail Rev. 2021 Mar 06; doi: 10.1007/s10741-021-10092-y. Epub 2021 Mar 06.

To compare the efficacy and safety of different mechanical circulatory support (MCS) devices in CS. A total of 24 studies (7 randomized controlled trials-RCTs-and 17 non-RCTs) involving 11,117 patients were entered in a Bayesian network meta-analysis. The primary endpoint...

Cite
Benenati S, Toma M, Canale C, et al. Mechanical circulatory support in patients with cardiogenic shock not secondary to cardiotomy: a network meta-analysis. Heart Fail Rev. 2021;doi: 10.1007/s10741-021-10092-y.
Benenati, S., Toma, M., Canale, C., Vergallo, R., Bona, R. D., Ricci, D., Canepa, M., Crimi, G., Santini, F., Ameri, P., & Porto, I. (2021). Mechanical circulatory support in patients with cardiogenic shock not secondary to cardiotomy: a network meta-analysis. Heart failure reviews, . https://doi.org/10.1007/s10741-021-10092-y
Benenati, Stefano, et al. "Mechanical circulatory support in patients with cardiogenic shock not secondary to cardiotomy: a network meta-analysis." Heart failure reviews vol. (2021). doi: https://doi.org/10.1007/s10741-021-10092-y
Benenati S, Toma M, Canale C, Vergallo R, Bona RD, Ricci D, Canepa M, Crimi G, Santini F, Ameri P, Porto I. Mechanical circulatory support in patients with cardiogenic shock not secondary to cardiotomy: a network meta-analysis. Heart Fail Rev. 2021 Mar 06; doi: 10.1007/s10741-021-10092-y. Epub 2021 Mar 06. PMID: 33677732.
Copy Download .nbib Format: NLM
Correction to: Polypharmacy definition and prevalence in heart failure: a systematic review.

Heart failure reviews

Beezer J, Al Hatrushi M, Husband A, Kurdi A, Forsyth P.
PMID: 34331624
Heart Fail Rev. 2021 Jul 31; doi: 10.1007/s10741-021-10149-y. Epub 2021 Jul 31.

No abstract available.

Cite
Beezer J, Al Hatrushi M, Husband A, et al. Correction to: Polypharmacy definition and prevalence in heart failure: a systematic review. Heart Fail Rev. 2021;doi: 10.1007/s10741-021-10149-y.
Beezer, J., Al Hatrushi, M., Husband, A., Kurdi, A., & Forsyth, P. (2021). Correction to: Polypharmacy definition and prevalence in heart failure: a systematic review. Heart failure reviews, . https://doi.org/10.1007/s10741-021-10149-y
Beezer, Janine, et al. "Correction to: Polypharmacy definition and prevalence in heart failure: a systematic review." Heart failure reviews vol. (2021). doi: https://doi.org/10.1007/s10741-021-10149-y
Beezer J, Al Hatrushi M, Husband A, Kurdi A, Forsyth P. Correction to: Polypharmacy definition and prevalence in heart failure: a systematic review. Heart Fail Rev. 2021 Jul 31; doi: 10.1007/s10741-021-10149-y. Epub 2021 Jul 31. PMID: 34331624.
Copy Download .nbib Format: NLM
Transcatheter therapies for secondary mitral regurgitation in advanced heart failure: what are we aiming for?.

Heart failure reviews

Scotti A, Munafò A, Margonato A, Godino C.
PMID: 34291400
Heart Fail Rev. 2021 Jul 22; doi: 10.1007/s10741-021-10148-z. Epub 2021 Jul 22.

A severe secondary mitral regurgitation (SMR) can be found in a significant portion of patients affected by advanced heart failure (AHF). Conventional therapies (optimal medical therapy, devices, surgery) present restricted clinical efficacy in this stage of the left ventricle...

Cite
Scotti A, Munafò A, Margonato A, et al. Transcatheter therapies for secondary mitral regurgitation in advanced heart failure: what are we aiming for?. Heart Fail Rev. 2021;doi: 10.1007/s10741-021-10148-z.
Scotti, A., Munafò, A., Margonato, A., & Godino, C. (2021). Transcatheter therapies for secondary mitral regurgitation in advanced heart failure: what are we aiming for?. Heart failure reviews, . https://doi.org/10.1007/s10741-021-10148-z
Scotti, Andrea, et al. "Transcatheter therapies for secondary mitral regurgitation in advanced heart failure: what are we aiming for?." Heart failure reviews vol. (2021). doi: https://doi.org/10.1007/s10741-021-10148-z
Scotti A, Munafò A, Margonato A, Godino C. Transcatheter therapies for secondary mitral regurgitation in advanced heart failure: what are we aiming for?. Heart Fail Rev. 2021 Jul 22; doi: 10.1007/s10741-021-10148-z. Epub 2021 Jul 22. PMID: 34291400.
Copy Download .nbib Format: NLM
Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers.

Heart failure reviews

Triposkiadis F, Xanthopoulos A, Parissis J, Butler J, Farmakis D.
PMID: 32524327
Heart Fail Rev. 2022 Jan;27(1):337-344. doi: 10.1007/s10741-020-09987-z.

Chronic heart failure (HF) is rare in the young and common in the elderly in the Western world. HF in the young is usually due to specific causes, predominantly or exclusively affecting the heart (adult congenital heart disease, different...

Cite
Triposkiadis F, Xanthopoulos A, Parissis J, et al. Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers. Heart Fail Rev. 2022;27(1):337-344doi: 10.1007/s10741-020-09987-z.
Triposkiadis, F., Xanthopoulos, A., Parissis, J., Butler, J., & Farmakis, D. (2022). Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers. Heart failure reviews, 27(1), 337-344. https://doi.org/10.1007/s10741-020-09987-z
Triposkiadis, Filippos, et al. "Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers." Heart failure reviews vol. 27,1 (2022): 337-344. doi: https://doi.org/10.1007/s10741-020-09987-z
Triposkiadis F, Xanthopoulos A, Parissis J, Butler J, Farmakis D. Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers. Heart Fail Rev. 2022 Jan;27(1):337-344. doi: 10.1007/s10741-020-09987-z. PMID: 32524327.
Copy Download .nbib Format: NLM
Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction.

Heart failure reviews

Barison A, Aimo A, Todiere G, Grigoratos C, Aquaro GD, Emdin M.
PMID: 32572736
Heart Fail Rev. 2022 Jan;27(1):191-205. doi: 10.1007/s10741-020-09998-w.

Heart failure with preserved ejection fraction (HFpEF) is characterized by an impaired ventricular filling resulting in the development of dyspnea and other HF symptoms. Even though echocardiography is the cornerstone to demonstrate structural and/or functional alterations of the heart...

Cite
Barison A, Aimo A, Todiere G, et al. Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction. Heart Fail Rev. 2022;27(1):191-205doi: 10.1007/s10741-020-09998-w.
Barison, A., Aimo, A., Todiere, G., Grigoratos, C., Aquaro, G. D., & Emdin, M. (2022). Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction. Heart failure reviews, 27(1), 191-205. https://doi.org/10.1007/s10741-020-09998-w
Barison, Andrea, et al. "Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction." Heart failure reviews vol. 27,1 (2022): 191-205. doi: https://doi.org/10.1007/s10741-020-09998-w
Barison A, Aimo A, Todiere G, Grigoratos C, Aquaro GD, Emdin M. Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction. Heart Fail Rev. 2022 Jan;27(1):191-205. doi: 10.1007/s10741-020-09998-w. PMID: 32572736.
Copy Download .nbib Format: NLM
Definition of left ventricular remodelling following ST-elevation myocardial infarction: a systematic review of cardiac magnetic resonance studies in the past decade.

Heart failure reviews

Legallois D, Hodzic A, Alexandre J, Dolladille C, Saloux E, Manrique A, Roule V, Labombarda F, Milliez P, Beygui F.
PMID: 32458217
Heart Fail Rev. 2022 Jan;27(1):37-48. doi: 10.1007/s10741-020-09975-3.

An increase in left ventricular volumes between baseline and follow-up imaging is the main criteria for the quantification of left ventricular remodelling (LVR) after ST-elevation myocardial infarction (STEMI), but without consensual definition. We aimed to review the criteria used...

Cite
Legallois D, Hodzic A, Alexandre J, et al. Definition of left ventricular remodelling following ST-elevation myocardial infarction: a systematic review of cardiac magnetic resonance studies in the past decade. Heart Fail Rev. 2022;27(1):37-48doi: 10.1007/s10741-020-09975-3.
Legallois, D., Hodzic, A., Alexandre, J., Dolladille, C., Saloux, E., Manrique, A., Roule, V., Labombarda, F., Milliez, P., & Beygui, F. (2022). Definition of left ventricular remodelling following ST-elevation myocardial infarction: a systematic review of cardiac magnetic resonance studies in the past decade. Heart failure reviews, 27(1), 37-48. https://doi.org/10.1007/s10741-020-09975-3
Legallois, Damien, et al. "Definition of left ventricular remodelling following ST-elevation myocardial infarction: a systematic review of cardiac magnetic resonance studies in the past decade." Heart failure reviews vol. 27,1 (2022): 37-48. doi: https://doi.org/10.1007/s10741-020-09975-3
Legallois D, Hodzic A, Alexandre J, Dolladille C, Saloux E, Manrique A, Roule V, Labombarda F, Milliez P, Beygui F. Definition of left ventricular remodelling following ST-elevation myocardial infarction: a systematic review of cardiac magnetic resonance studies in the past decade. Heart Fail Rev. 2022 Jan;27(1):37-48. doi: 10.1007/s10741-020-09975-3. PMID: 32458217.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 314 entries